Fairvalue-Calculator Fairvalue-Calculator
EN DE

Onyx Healthcare Inc (6569) Fair Value & Analysis

Healthcare · TW · Market cap 4.4B TWD

Price112.50 TWD
Fair Value43.29 TWD
Upside-61.5%
Quality95/100
Evidence: High Range 36.59 TWD – 51.82 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Onyx Healthcare Inc (6569) currently trades at 112.50 TWD, while our model-based Fair Value estimate is 43.29 TWD — implying the stock looks roughly 61.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Onyx Healthcare Inc., a professional medical IT company, engages in the design, manufacture, and trade of medical computers and peripherals for hospital/clinical IT market in Taiwan, the United States, and internationally. The company offers medical AI computer; medical tablet, power bank, and display; and medical panel and box PC. It also provides ODM/OEM services; smart view medical stations; fan less slim panel PC; medical display; healthcare infotainment; and medical pc and mobile computing cart. The company was incorporated in 2010 and is based in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Onyx Healthcare Inc (6569) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 43.29 TWD versus a price of 112.50 TWD — about −62% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6569?
Our 21-model fair value for Onyx Healthcare Inc is 43.29 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 112.50 TWD.
What is the quality score of 6569?
Onyx Healthcare Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.